多参数磁共振成像在诊断模拟前列腺癌的肉芽肿性前列腺炎中的作用
这项前瞻性单中心研究纳入10例因中高危膀胱癌接受膀胱内卡介苗灌注的男性患者,在经尿道膀胱肿瘤切除术前行多参数磁共振成像、血清前列腺特异性抗原和直肠指检。灌注后前列腺特异性抗原由1.7 ng/ml升至4.3 ng/ml(p=0.005),直肠指检异常者达80%,PI-RADS≥3病灶显著增多(p=0.004);作者认为灌注后出现这些改变应提示肉芽肿性前列腺炎,可能避免不必要的活检。
要点
- 膀胱内卡介苗灌注后前列腺特异性抗原升高、直肠指检异常和PI-RADS≥3病灶可提示肉芽肿性前列腺炎。
- 本研究灌注后前列腺特异性抗原由1.7 ng/ml升至4.3 ng/ml(p=0.005),前列腺特异性抗原密度由0.04升至0.10(p=0.012)。
- 作者认为灌注后出现上述改变可能避免不必要的活检。
核心结论
- 肉芽肿性前列腺炎是膀胱内卡介苗灌注的罕见并发症,灌注后出现前列腺特异性抗原升高、直肠指检异常和PI-RADS≥3病灶应提示肉芽肿性前列腺炎,可能避免不必要的活检。
研究设计与样本
- 前瞻性单中心研究,纳入10例因中高危膀胱癌接受膀胱内卡介苗灌注的男性患者,灌注前后评估血清前列腺特异性抗原和直肠指检,对前列腺特异性抗原升高和/或直肠指检异常者行多参数磁共振成像,随后行磁共振融合加系统前列腺活检。
关键影像表现/征象
- 所有患者卡介苗灌注前直肠指检正常,灌注后80%的患者检出异常(p=0.008)。
- 卡介苗灌注后所有患者PI-RADS≥3病灶显著增多(p=0.004)。
诊断标准与关键数值
- 以PI-RADS≥3作为病灶判定阈值,卡介苗灌注后所有患者该阈值病灶显著增多(p=0.004)。
- 卡介苗灌注后前列腺特异性抗原4.3 ng/ml vs 灌注前1.7 ng/ml(p=0.005)。
- 卡介苗灌注后前列腺特异性抗原密度0.10 vs 灌注前0.04(p=0.012)。
临床应用与阅片要点
- 对膀胱内卡介苗灌注后前列腺特异性抗原升高和/或直肠指检异常的患者行多参数磁共振成像评估。
- 阅片时注意卡介苗灌注后出现的PI-RADS≥3病灶可能对应肉芽肿性前列腺炎。
- 作者认为结合灌注后前列腺特异性抗原升高、直肠指检异常和PI-RADS≥3病灶可能避免不必要的活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Aimed to investigate the role of multiparametric magnetic resonance imaging (mp-MRI) in the diagnosis of granulomatous prostatitis caused by intravesical Bacillus Calmette-Guérin (BCG).
METHODS: In this prospective, single-center study, 10 male patients who were given intravesical BCG due to intermediate- and high-risk bladder cancer were included. Before transurethral resection of bladder tumors (TURB), all patients were evaluated by mp-MRI, serum prostate-specific antigen (PSA), and digital rectal examination (DRE). Serum PSA levels and DRE findings were evaluated before and after intravesical BCG treatment. Prostate mp-MRI was performed for patients with elevated levels of serum PSA and/or with abnormal DRE findings. Then, MRI fusion + systematic prostate biopsy was performed. Demographic data of the patients before and after intravesical BCG were compared.
RESULTS: The average age of the patients was 66.9 years (55-87 years). While PSA was 1.7 ng/ml before intravesical BCG treatment, it was 4.3 ng/ml after intravesical BCG treatment (p = 0.005). PSA density (PSAD) was 0.04 and 0.10 before and after the treatment, respectively (p = 0.012). DRE findings of all patients were normal before the treatment. However, abnormal findings were detected in 80% of them after the treatment (p = 0.008). PI-RADS ≥ 3 lesions were found to be significantly higher in all patients after intravesical BCG (p = 0.004).
CONCLUSION: Granulomatous prostatitis is a rare complication of intravesical BCG. High PSA, abnormal DRE, and PI-RADS ≥ 3 lesions detected after intravesical BCG should suggest granulomatous prostatitis and unnecessary biopsies may be avoided.
引用
- Ogreden E, Oguz U, Demirelli E, et al. The role of multiparametric magnetic resonance ımaging in the diagnosis of granulomatous prostatitis mimicking prostate cancer. Abdom Radiol (NY). 2024. PMID: 38652127. doi:10.1007/s00261-024-04288-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。